DK0547102T3 - Opløseliggørelse af proteiner på aktiv form - Google Patents

Opløseliggørelse af proteiner på aktiv form

Info

Publication number
DK0547102T3
DK0547102T3 DK91915661T DK91915661T DK0547102T3 DK 0547102 T3 DK0547102 T3 DK 0547102T3 DK 91915661 T DK91915661 T DK 91915661T DK 91915661 T DK91915661 T DK 91915661T DK 0547102 T3 DK0547102 T3 DK 0547102T3
Authority
DK
Denmark
Prior art keywords
protein
active form
solubilization
proteins
refolding
Prior art date
Application number
DK91915661T
Other languages
Danish (da)
English (en)
Inventor
Kumar Puri Nirdosh
Enzo Crivelli
Original Assignee
Natinco Nv
Southern Cross Biotech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natinco Nv, Southern Cross Biotech Pty Ltd filed Critical Natinco Nv
Application granted granted Critical
Publication of DK0547102T3 publication Critical patent/DK0547102T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK91915661T 1990-09-05 1991-08-29 Opløseliggørelse af proteiner på aktiv form DK0547102T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPK215990 1990-09-05
PCT/AU1991/000395 WO1992004382A1 (en) 1990-09-05 1991-08-29 Solubilization of proteins in active forms

Publications (1)

Publication Number Publication Date
DK0547102T3 true DK0547102T3 (da) 1999-04-19

Family

ID=3774938

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91915661T DK0547102T3 (da) 1990-09-05 1991-08-29 Opløseliggørelse af proteiner på aktiv form

Country Status (8)

Country Link
EP (1) EP0547102B1 (de)
AT (1) ATE168115T1 (de)
AU (1) AU664021B2 (de)
CA (1) CA2090701C (de)
DE (1) DE69129747T2 (de)
DK (1) DK0547102T3 (de)
ES (1) ES2119779T3 (de)
WO (1) WO1992004382A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4665193A (en) * 1992-07-02 1994-01-31 Pitman-Moore, Inc. A process for recovering a recombinant protein, in biologically active form, from a solution containing inactive protein
DK44593D0 (da) * 1993-04-20 1993-04-20 Novo Nordisk As Fremgangsmaade til fremstilling af et polypeptid
KR960704934A (ko) * 1993-09-22 1996-10-09 이나모리 준스케 항혈전활성을 갖는 펩티드 및 이의 제조방법(Peptide having antithrombotic activity and process for producing the same)
ZA955789B (en) * 1994-07-15 1996-03-11 Novo Nordisk As A method of converting a hydrophobic derivative of a polypeptide into the native form
DE10309691B4 (de) * 2003-02-28 2018-10-04 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Gewinnung von löslichen Proteinen aus der Biomasse rekombinanter Mikroorganismen
EP3366692A1 (de) * 2009-06-22 2018-08-29 Amgen, Inc Proteinneufaltung mit einem chemisch gesteuerten redoxzustand
EP2445924B2 (de) 2009-06-25 2023-12-13 Amgen Inc. Vefahren zur aufreinigung von proteinen aus prokaryotischen zellen
EP3299378B1 (de) 2013-02-12 2019-07-31 Bristol-Myers Squibb Company Rückfaltungsverfahren für protein mit hohem ph-wert
EP3744728A1 (de) 2013-02-12 2020-12-02 Bristol-Myers Squibb Company Tangentialstromfiltration auf der basis von proteinrückfaltungsverfahren
US9982012B2 (en) 2013-03-29 2018-05-29 Dr. Reddy's Laboratories Limited Refolding of granulocyte colony stimulating factor
EP3344651B1 (de) 2015-09-02 2022-03-02 Merck Sharp & Dohme Corp. Verfahren zur gewinnung von insulin mit korrekt geformten disulfidbindungen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6079000A (ja) * 1983-10-04 1985-05-04 Takeda Chem Ind Ltd ヒトγ型インタ−フエロン単量体の製造法
ATE92935T1 (de) * 1984-12-06 1993-08-15 Synergen Biolog Inc Serinproteaseinhibitoren und isolierungsverfahren dazu.
DE3537708A1 (de) * 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
US4766205A (en) * 1985-11-13 1988-08-23 Beatrice Companies, Inc. Method for isolation of recombinant polypeptides in biologically active forms
DE3611817A1 (de) * 1986-04-08 1987-10-15 Boehringer Mannheim Gmbh Verfahren zur renaturierung von proteinen
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
IL86090A (en) * 1987-04-16 1993-03-15 Cetus Oncology Corp Production of purified, biologically active, bacterially produced recombinant human csf-1
EP0295859B1 (de) * 1987-06-15 1994-11-17 Southern Cross Biotech Pty.Ltd. Herstellung von Proteinen in aktiver Form
WO1989001046A1 (en) * 1987-07-29 1989-02-09 Schering Biotech Corporation Purification of human interleukin-4 expressed in escherichia coli
CA1340586C (en) * 1988-09-23 1999-06-08 Cetus Corporation Process for recovering microbially produced interferon-beta
DE3832898A1 (de) * 1988-09-28 1990-04-12 Boehringer Mannheim Gmbh Praeparat von in prokaryonten exprimiertem plasminogenaktivator
DE3901719A1 (de) * 1989-01-21 1990-07-26 Hoechst Ag Verfahren zur herstellung eines insulinvorlaeufers
DE3901718A1 (de) * 1989-01-21 1990-07-26 Hoechst Ag Verfahren zur renaturierung falscher rekombinanten von insulinvorlaeufern
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US5235043A (en) * 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
DE4113750A1 (de) * 1991-04-26 1992-10-29 Boehringer Mannheim Gmbh Verbesserung der renaturierung bei der sekretion von disulfidverbrueckten proteinen

Also Published As

Publication number Publication date
EP0547102A1 (de) 1993-06-23
EP0547102B1 (de) 1998-07-08
ES2119779T3 (es) 1998-10-16
AU664021B2 (en) 1995-11-02
ATE168115T1 (de) 1998-07-15
WO1992004382A1 (en) 1992-03-19
EP0547102A4 (de) 1994-04-27
CA2090701C (en) 2000-05-16
AU8403591A (en) 1992-03-30
DE69129747T2 (de) 1998-11-12
CA2090701A1 (en) 1992-03-10
DE69129747D1 (de) 1998-08-13

Similar Documents

Publication Publication Date Title
DK322188A (da) Fremgangsmaade til fremstilling af protein
ATE229978T1 (de) Helicobacter proteine und impstoffe
ATE210127T1 (de) 6-substituierte mycophenolsäurederivate mit immun suppressiver wirkung
ATE211467T1 (de) 4-amino-derivate der mycophenolsäure mit immun suppressiver wirkung
DK0770397T3 (da) Newcastle disease viruskombinationsvaccine
IS3824A (is) Protein með bundið polyethylen og aðferð til framleiðslu þess
BR9915852A (pt) Conjugado de hapteno-portador para tratamento e prevenção do vìcio da nicotina
ES2117052T3 (es) Induccion de respuestas de linfocitos t citotoxicos.
DK0538300T3 (da) O-Glycosyleret IFN-alfa
DK183386A (da) Sucralfatsuspension
DK0429570T3 (da) Osteoinducerende præparater
DK0507933T3 (da) Nær-vaskulariserende implantationsmateriale
DK0526544T3 (da) Terapeutiske anvendelser af actinbindende forbindelser
MX9102353A (es) N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen.
DK0547102T3 (da) Opløseliggørelse af proteiner på aktiv form
BR9709845A (pt) Preparação aquosa de insulina formulação farmacêutica parenteral e processo para aumentar a estabilidade química de uma preparação de insulina
FR2522967B1 (fr) Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
DE69101634D1 (de) Rekombinant hergestellte blutfaktoren, verfahren zur exprimierung besagter blutfaktoren sowie in besagtem prozess verwendeter rekombinanter vaccina-virus.
DE69531793D1 (de) Immunogene zubereitungen
DE59010164D1 (de) Wässrige Polymerisatzubereitungen
SE8700156L (sv) Kosmetiska kompositioner med hudlugnande och hudgenerande effekt och forfarande for framstellning derav
FI944907A (fi) Uusi antineoplastinen sytokiini
ATE265234T1 (de) Pharmazeutische zusammensetzung von hydrophob modifizierten hedgehog-proteinen und deren verwendung
ATE123302T1 (de) Rhoptry-membran-antigen von -i(plasmodium falciparum).
ATE80143T1 (de) Isomere formyl-trimethylbicyclo(2,2,2)oct-7-ene.